Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Aaronson

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Translational Behavioral Medicine|February 10, 2018
Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort studyKathryn L Taylor, George Luta, Richard M Hoffman, et al.
Urology|December 27, 2022
Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective CohortVidit Sharma, Karim Chamie, Mark Schoenberg, et al.
Health Education Research|April 6, 2017
Physicians' perspectives on the informational needs of low-risk prostate cancer patientsCharlotte J Hagerman, Paula G Bellini, Kim M Davis, et al.
World Journal of Urology|April 17, 2016
Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancerAlex Z Fu, Huei-Ting Tsai, Reina Haque, et al.
The Journal of Urology|December 24, 2016
Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate CancerAlex Z Fu, Huei-Ting Tsai, Reina Haque, et al.
Urology|June 16, 2018
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause MortalityLauren P Wallner, Julia R DiBello, Bonnie H Li, et al.
American Journal of Epidemiology|December 6, 2023
Environmental and occupational exposures and prognosis in patients with non-muscle-invasive bladder cancer in the Be-Well StudyZinian Wang, Marilyn L Kwan, Reina Haque, et al.
Mayo Clinic Proceedings|January 28, 2017
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic HyperplasiaLauren P Wallner, Julia R DiBello, Bonnie H Li, et al.
JAMA Network Open|November 30, 2022
Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well StudyMarilyn L Kwan, Reina Haque, Kelly C Young-Wolff, et al.
The Journal of Urology|June 7, 2024
The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Guérin in Treating Nonmuscle-Invasive Bladder CancerMarilyn L Kwan, Zinian Wang, Reina Haque, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Translational Behavioral Medicine|February 10, 2018
Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort studyKathryn L Taylor, George Luta, Richard M Hoffman, et al.
Urology|December 27, 2022
Natural History of Multiple Recurrences in Intermediate-Risk Non-Muscle Invasive Bladder Cancer: Lessons From a Prospective CohortVidit Sharma, Karim Chamie, Mark Schoenberg, et al.
Health Education Research|April 6, 2017
Physicians' perspectives on the informational needs of low-risk prostate cancer patientsCharlotte J Hagerman, Paula G Bellini, Kim M Davis, et al.
World Journal of Urology|April 17, 2016
Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancerAlex Z Fu, Huei-Ting Tsai, Reina Haque, et al.
The Journal of Urology|December 24, 2016
Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate CancerAlex Z Fu, Huei-Ting Tsai, Reina Haque, et al.
Urology|June 16, 2018
The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause MortalityLauren P Wallner, Julia R DiBello, Bonnie H Li, et al.
American Journal of Epidemiology|December 6, 2023
Environmental and occupational exposures and prognosis in patients with non-muscle-invasive bladder cancer in the Be-Well StudyZinian Wang, Marilyn L Kwan, Reina Haque, et al.
Mayo Clinic Proceedings|January 28, 2017
5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic HyperplasiaLauren P Wallner, Julia R DiBello, Bonnie H Li, et al.
JAMA Network Open|November 30, 2022
Smoking Behaviors and Prognosis in Patients With Non-Muscle-Invasive Bladder Cancer in the Be-Well StudyMarilyn L Kwan, Reina Haque, Kelly C Young-Wolff, et al.
The Journal of Urology|June 7, 2024
The Influence of Dietary Isothiocyanates on the Effectiveness of Mitomycin C and Bacillus Calmette-Guérin in Treating Nonmuscle-Invasive Bladder CancerMarilyn L Kwan, Zinian Wang, Reina Haque, et al.
Pageof 5